- Home
- ODV vs AMRN Comparison
ODV vs AMRN Comparison
Compare ODV & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODV
- AMRN
- Stock Information
- Founded
- ODV 2005
- AMRN 1989
- Country
- ODV Canada
- AMRN Ireland
- Employees
- ODV N/A
- AMRN N/A
- Industry
- ODV Precious Metals
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- ODV Basic Materials
- AMRN Health Care
- Exchange
- ODV Nasdaq
- AMRN Nasdaq
- Market Cap
- ODV 204.7M
- AMRN 236.4M
- IPO Year
- ODV N/A
- AMRN 1993
- Fundamental
- Price
- ODV $1.41
- AMRN $0.50
- Analyst Decision
- ODV
- AMRN Hold
- Analyst Count
- ODV 0
- AMRN 2
- Target Price
- ODV N/A
- AMRN N/A
- AVG Volume (30 Days)
- ODV 402.7K
- AMRN 1.2M
- Earning Date
- ODV 11-12-2024
- AMRN 10-30-2024
- Dividend Yield
- ODV N/A
- AMRN N/A
- EPS Growth
- ODV N/A
- AMRN N/A
- EPS
- ODV N/A
- AMRN N/A
- Revenue
- ODV $8,486,621.00
- AMRN $241,021,000.00
- Revenue This Year
- ODV N/A
- AMRN N/A
- Revenue Next Year
- ODV $239.72
- AMRN N/A
- P/E Ratio
- ODV N/A
- AMRN N/A
- Revenue Growth
- ODV N/A
- AMRN N/A
- 52 Week Low
- ODV $1.40
- AMRN $0.50
- 52 Week High
- ODV $3.19
- AMRN $1.37
- Technical
- Relative Strength Index (RSI)
- ODV 25.18
- AMRN 32.91
- Support Level
- ODV $1.73
- AMRN $0.54
- Resistance Level
- ODV $1.83
- AMRN $0.58
- Average True Range (ATR)
- ODV 0.10
- AMRN 0.04
- MACD
- ODV -0.04
- AMRN -0.01
- Stochastic Oscillator
- ODV 0.96
- AMRN 2.97
About ODV Osisko Development Corp.
Osisko Development Corp is a mineral exploration and development company engaged in the acquisition, exploration and development of precious metals resource properties in North America. The company is focused on exploring and developing its mining assets, including the Cariboo Gold Project in British Columbia, the San Antonio gold project in Mexico and the Trixie test mine in the USA. The Company manages its business through the exploration, evaluation and development activities of its projects.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.